Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Testando a adição do medicamento de imunoterapia pembrolizumabe ao tratamento de quimioterapia usual (paclitaxel e carboplatina) no estágio III-IV ou câncer de endométrio recorrente

11 de novembro de 2026 atualizado por: National Cancer Institute (NCI)

Um estudo randomizado de fase III, controlado por placebo, de pembrolizumabe (MK-3475, NSC nº 776864) além de paclitaxel e carboplatina para estágio mensurável III ou IVA, estágio IVB ou câncer de endométrio recorrente

This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back after a period of improvement (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer.

Visão geral do estudo

Descrição detalhada

PRIMARY OBJECTIVE:

I. To evaluate the efficacy of pembrolizumab (MK-3475) in combination with paclitaxel and carboplatin in patients with advanced stage (measurable stage III or IVA), stage IVB and recurrent endometrial cancer.

SECONDARY OBJECTIVES:

I. To determine the nature, frequency and degree of toxicity as assessed by Common Terminology Criteria for Adverse Events (CTCAE) for each treatment arm.

II. To evaluate blinded independent central review (BICR) assessed or investigator assessed objective response rate (ORR) as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 by treatment arm and by mismatch repair (MMR) immunohistochemistry (IHC) status in patients who enter the study with measurable disease.

III. To evaluate BICR assessed or investigator assessed duration of response (DOR) by treatment arm and by MMR IHC status in patients who enter the study with measurable disease.

IV. To evaluate the effect of pembrolizumab (MK-3475) on overall survival (OS) in patients with mismatch repair protein proficient (pMMR) or mismatch repair deficiency (dMMR).

V. To determine whether the addition of pembrolizumab (MK-3475) to standard combination chemotherapy is associated with improved patient reported physical function as measured with the Patient-Reported Outcomes Measurement Information System (PROMIS)-physical function scale (short form), quality of life as measured with the Functional Assessment of Cancer Therapy (FACT) - Endometrial Trial Outcome Index (En TOI) and worsened fatigue as measured with the PROMIS-Fatigue scale (short form) in the pMMR patients.

VI. To determine concordance between institutional MMR IHC testing and centralized MMR IHC.

EXPLORATORY OBJECTIVES:

I. To explore the correlation between patient-reported physical function as measured with the PROMIS-physical function scale (short form) and quality of life as measure with the FACT-En TOI.

II. To explore whether the addition of pembrolizumab (MK-3475) to standard combination chemotherapy is associated with self-reported neurotoxicity as measured with the FACT/Gynecologic Oncology Group Neurotoxicity (GOG-Ntx) subscale (short) and the extent to which patients differ on their self-reported bother from side effects of cancer therapy in the pMMR patients.

III. To evaluate the efficacy of pembrolizumab (MK-3475) in combination with paclitaxel and carboplatin in patients with advanced stage (measurable stage III or IVA), stage IVB and recurrent endometrial cancer by Programmed Death Ligand 1 (PD-L1) IHC (positive versus [vs] negative).

IV. To assess the association between PD-L1 IHC (positive vs negative) and mismatch repair status (pMMR and dMMR).

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I:

COMBINATION PHASE: Patients receive placebo intravenously (IV) over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with stable disease (SD) or partial response (PR) who still have measurable disease may continue treatment for up to a total 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

On February 6, 2023, all patient treatment assignments were unblinded. Patients randomized to Arm I will not receive additional placebo infusions.

ARM II:

COMBINATION PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo computed tomography (CT) scan throughout the study.

After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.

Tipo de estudo

Intervencional

Inscrição (Real)

813

Estágio

  • Fase 3

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • New Brunswick
      • Moncton, New Brunswick, Canadá, E1C 6Z8
        • The Moncton Hospital
    • Ontario
      • Barrie, Ontario, Canadá, L4M 6M2
        • Royal Victoria Regional Health Centre
      • Greater Sudbury, Ontario, Canadá, P3E 5J1
        • Health Sciences North
      • Hamilton, Ontario, Canadá, L8V 5C2
        • Juravinski Cancer Centre at Hamilton Health Sciences
      • Kingston, Ontario, Canadá, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Canadá, N6A 4L6
        • London Regional Cancer Program
      • Oshawa, Ontario, Canadá, L1G 2B9
        • Lakeridge Health Oshawa
      • Sault Ste. Marie, Ontario, Canadá, P6B 0A8
        • Algoma District Cancer Program Sault Area Hospital
      • Toronto, Ontario, Canadá, M5G 2M9
        • University Health Network-Princess Margaret Hospital
      • Toronto, Ontario, Canadá, M4N 3M5
        • Odette Cancer Centre- Sunnybrook Health Sciences Centre
    • Quebec
      • Laval, Quebec, Canadá, H7M 3L9
        • Hopital de la Cite-de-la-Sante
      • Montreal, Quebec, Canadá, H2X 3E4
        • CHUM - Centre Hospitalier de l'Universite de Montreal
    • Saskatchewan
      • Regina, Saskatchewan, Canadá, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, Canadá, S7N 4H4
        • Saskatoon Cancer Centre
      • Daegu, Coréia do Sul, 41404
        • Kyungpook National University Chilgok Hospital
      • Seoul, Coréia do Sul, 05505
        • Asan Medical Center
      • Seoul, Coréia do Sul, 06273
        • Gangnam Severance Hospital
      • Seoul, Coréia do Sul, 120-752
        • Yonsei University Health System-Severance Hospital
      • Seoul, Coréia do Sul, 139-706
        • Korea Cancer Center Hospital
    • Daegu
      • Dalseo-gu, Daegu, Coréia do Sul, 42601
        • Keimyung University-Dongsan Medical Center
    • Gyeongsangnam-do
      • Seoul, Gyeongsangnam-do, Coréia do Sul, 51353
        • Samsung Changwon Hospital
    • Kyeonggi-do
      • Seongnam, Kyeonggi-do, Coréia do Sul, 463-707
        • Seoul National University Bundang Hospital
    • Alabama
      • Birmingham, Alabama, Estados Unidos, 35233
        • University of Alabama at Birmingham Cancer Center
    • Alaska
      • Anchorage, Alaska, Estados Unidos, 99508
        • Alaska Women's Cancer Care
    • Arizona
      • Goodyear, Arizona, Estados Unidos, 85338
        • CTCA at Western Regional Medical Center
    • Arkansas
      • Jonesboro, Arkansas, Estados Unidos, 72401
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
      • Little Rock, Arkansas, Estados Unidos, 72205
        • University of Arkansas for Medical Sciences
    • California
      • Baldwin Park, California, Estados Unidos, 91706
        • Kaiser Permanente-Baldwin Park
      • Bellflower, California, Estados Unidos, 90706
        • Kaiser Permanente-Bellflower
      • Berkeley, California, Estados Unidos, 94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Clovis, California, Estados Unidos, 93611
        • Community Cancer Institute
      • Duarte, California, Estados Unidos, 91010
        • City of Hope Comprehensive Cancer Center
      • Harbor City, California, Estados Unidos, 90710
        • Kaiser Permanente South Bay
      • Irvine, California, Estados Unidos, 92618
        • Kaiser Permanente-Irvine
      • La Jolla, California, Estados Unidos, 92093
        • UC San Diego Moores Cancer Center
      • Lancaster, California, Estados Unidos, 93534
        • City of Hope Antelope Valley
      • Los Angeles, California, Estados Unidos, 90033
        • USC / Norris Comprehensive Cancer Center
      • Los Angeles, California, Estados Unidos, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Estados Unidos, 90095
        • UCLA / Jonsson Comprehensive Cancer Center
      • Los Angeles, California, Estados Unidos, 90027
        • Kaiser Permanente Los Angeles Medical Center
      • Los Angeles, California, Estados Unidos, 90033
        • Los Angeles General Medical Center
      • Mountain View, California, Estados Unidos, 94040
        • Palo Alto Medical Foundation-Gynecologic Oncology
      • Oakland, California, Estados Unidos, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Estados Unidos, 92868
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
      • Orange, California, Estados Unidos, 92868
        • Saint Joseph Hospital - Orange
      • Rancho Mirage, California, Estados Unidos, 92270
        • Eisenhower Medical Center
      • Redding, California, Estados Unidos, 96001
        • Mercy Regional Cancer Center
      • Redding, California, Estados Unidos, 96002
        • Mercy Oncology Center
      • Riverside, California, Estados Unidos, 92505
        • Kaiser Permanente-Riverside
      • Roseville, California, Estados Unidos, 95661
        • Kaiser Permanente-Roseville
      • Sacramento, California, Estados Unidos, 95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento, California, Estados Unidos, 95814
        • Kaiser Permanente Downtown Commons
      • Sacramento, California, Estados Unidos, 95816
        • Mercy Cancer Center - Sacramento
      • San Diego, California, Estados Unidos, 92120
        • Kaiser Permanente-San Diego Zion
      • San Diego, California, Estados Unidos, 92134
        • Naval Medical Center -San Diego
      • San Francisco, California, Estados Unidos, 94115
        • Kaiser Permanente-San Francisco
      • San Francisco, California, Estados Unidos, 94158
        • UCSF Medical Center-Mission Bay
      • San Francisco, California, Estados Unidos, 94115
        • California Pacific Medical Center-Pacific Campus
      • San Francisco, California, Estados Unidos, 94110
        • Zuckerberg San Francisco General Hospital
      • San Jose, California, Estados Unidos, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Leandro, California, Estados Unidos, 94577
        • Kaiser Permanente San Leandro
      • San Marcos, California, Estados Unidos, 92078
        • Kaiser Permanente-San Marcos
      • Santa Clara, California, Estados Unidos, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • South Pasadena, California, Estados Unidos, 91030
        • City of Hope South Pasadena
      • South San Francisco, California, Estados Unidos, 94080
        • Kaiser Permanente-South San Francisco
      • Sunnyvale, California, Estados Unidos, 94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Upland, California, Estados Unidos, 91786
        • City of Hope Upland
      • Vallejo, California, Estados Unidos, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Estados Unidos, 94596
        • Kaiser Permanente-Walnut Creek
      • Walnut Creek, California, Estados Unidos, 94598
        • John Muir Medical Center-Walnut Creek
    • Colorado
      • Colorado Springs, Colorado, Estados Unidos, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Estados Unidos, 80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs, Colorado, Estados Unidos, 80920
        • Memorial Hospital North
      • Fort Collins, Colorado, Estados Unidos, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Estados Unidos, 80528
        • Cancer Care and Hematology-Fort Collins
      • Greeley, Colorado, Estados Unidos, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, Estados Unidos, 80631
        • Banner North Colorado Medical Center
      • Loveland, Colorado, Estados Unidos, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, Estados Unidos, 80539
        • Banner North Colorado Medical Center - Loveland Campus
    • Connecticut
      • Danbury, Connecticut, Estados Unidos, 06810
        • Danbury Hospital
      • Guilford, Connecticut, Estados Unidos, 06437
        • Smilow Cancer Hospital Care Center - Guilford
      • Hartford, Connecticut, Estados Unidos, 06105
        • Smilow Cancer Hospital Care Center at Saint Francis
      • Hartford, Connecticut, Estados Unidos, 06102
        • Hartford Hospital
      • New Britain, Connecticut, Estados Unidos, 06050
        • The Hospital of Central Connecticut
      • New Haven, Connecticut, Estados Unidos, 06520
        • Yale University
      • North Haven, Connecticut, Estados Unidos, 06473
        • Yale-New Haven Hospital North Haven Medical Center
      • Norwalk, Connecticut, Estados Unidos, 06856
        • Norwalk Hospital
      • Stamford, Connecticut, Estados Unidos, 06904
        • Stamford Hospital/Bennett Cancer Center
      • Torrington, Connecticut, Estados Unidos, 06790
        • Smilow Cancer Hospital-Torrington Care Center
      • Trumbull, Connecticut, Estados Unidos, 06611
        • Smilow Cancer Hospital Care Center-Trumbull
      • Waterbury, Connecticut, Estados Unidos, 06708
        • Smilow Cancer Hospital-Waterbury Care Center
      • Waterford, Connecticut, Estados Unidos, 06385
        • Smilow Cancer Hospital Care Center - Waterford
    • Delaware
      • Newark, Delaware, Estados Unidos, 19713
        • Helen F Graham Cancer Center
    • District of Columbia
      • Washington D.C., District of Columbia, Estados Unidos, 20010
        • MedStar Washington Hospital Center
      • Washington D.C., District of Columbia, Estados Unidos, 20016
        • Sibley Memorial Hospital
    • Florida
      • Bradenton, Florida, Estados Unidos, 34205
        • Florida Cancer Specialists - Bradenton Cancer Center
      • Sarasota, Florida, Estados Unidos, 34239
        • Sarasota Memorial Hospital
      • Sarasota, Florida, Estados Unidos, 34232
        • Florida Cancer Specialists - Sarasota
      • Sarasota, Florida, Estados Unidos, 34239
        • Florida Cancer Specialists - Sarasota Downtown
      • Venice, Florida, Estados Unidos, 34285
        • Florida Cancer Specialists - Venice Island
      • Venice, Florida, Estados Unidos, 34275
        • Florida Cancer Specialists - Venice Pinebrook
    • Georgia
      • Atlanta, Georgia, Estados Unidos, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Estados Unidos, 30322
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta, Georgia, Estados Unidos, 30342
        • Emory Saint Joseph's Hospital
      • Atlanta, Georgia, Estados Unidos, 30303
        • Grady Health System
      • Atlanta, Georgia, Estados Unidos, 30342
        • Northside Hospital
      • Austell, Georgia, Estados Unidos, 30106
        • WellStar Cobb Hospital
      • Fayetteville, Georgia, Estados Unidos, 30214
        • Piedmont Fayette Hospital
      • Gainesville, Georgia, Estados Unidos, 30501
        • Northeast Georgia Medical Center-Gainesville
      • Marietta, Georgia, Estados Unidos, 30060
        • Wellstar Kennestone Hospital
      • Marietta, Georgia, Estados Unidos, 30060
        • WellStar Health System Inc
      • Newnan, Georgia, Estados Unidos, 30265
        • CTCA at Southeastern Regional Medical Center
      • Roswell, Georgia, Estados Unidos, 30076
        • WellStar North Fulton Hospital
      • Savannah, Georgia, Estados Unidos, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
      • Savannah, Georgia, Estados Unidos, 31404
        • Memorial Health University Medical Center
      • Smyrna, Georgia, Estados Unidos, 30080
        • WellStar Vinings Health Park
    • Hawaii
      • Honolulu, Hawaii, Estados Unidos, 96813
        • Queen's Medical Center
      • Honolulu, Hawaii, Estados Unidos, 96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise, Idaho, Estados Unidos, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Estados Unidos, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Estados Unidos, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Fruitland, Idaho, Estados Unidos, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Estados Unidos, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Estados Unidos, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Estados Unidos, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Twin Falls, Idaho, Estados Unidos, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60611
        • Northwestern University
      • Chicago, Illinois, Estados Unidos, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Estados Unidos, 60612
        • University of Illinois
      • Chicago, Illinois, Estados Unidos, 60612
        • Rush MD Anderson Cancer Center
      • Danville, Illinois, Estados Unidos, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Estados Unidos, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Effingham, Illinois, Estados Unidos, 62401
        • Crossroads Cancer Center
      • Evanston, Illinois, Estados Unidos, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Geneva, Illinois, Estados Unidos, 60134
        • Northwestern Medicine Cancer Center Delnor
      • Glenview, Illinois, Estados Unidos, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Harvey, Illinois, Estados Unidos, 60426
        • Ingalls Memorial Hospital
      • Highland Park, Illinois, Estados Unidos, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Mattoon, Illinois, Estados Unidos, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Maywood, Illinois, Estados Unidos, 60153
        • Loyola University Medical Center
      • New Lenox, Illinois, Estados Unidos, 60451
        • UC Comprehensive Cancer Center at Silver Cross
      • O'Fallon, Illinois, Estados Unidos, 62269
        • Cancer Care Center of O'Fallon
      • Orland Park, Illinois, Estados Unidos, 60462
        • University of Chicago Medicine-Orland Park
      • Springfield, Illinois, Estados Unidos, 62702
        • Springfield Clinic
      • Urbana, Illinois, Estados Unidos, 61801
        • Carle Cancer Center
      • Warrenville, Illinois, Estados Unidos, 60555
        • Northwestern Medicine Cancer Center Warrenville
      • Zion, Illinois, Estados Unidos, 60099
        • Midwestern Regional Medical Center
    • Indiana
      • Crown Point, Indiana, Estados Unidos, 46307
        • Northwest Cancer Center - Crown Point
      • Dyer, Indiana, Estados Unidos, 46311
        • Northwest Oncology LLC
      • Hobart, Indiana, Estados Unidos, 46342
        • Northwest Cancer Center - Hobart
      • Hobart, Indiana, Estados Unidos, 46342
        • Saint Mary Medical Center
      • Indianapolis, Indiana, Estados Unidos, 46237
        • Franciscan Health Indianapolis
      • Indianapolis, Indiana, Estados Unidos, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Estados Unidos, 46219
        • Community Cancer Center East
      • Indianapolis, Indiana, Estados Unidos, 46227
        • Community Cancer Center South
      • Indianapolis, Indiana, Estados Unidos, 46256
        • Community Cancer Center North
      • Indianapolis, Indiana, Estados Unidos, 46260
        • Ascension Saint Vincent Indianapolis Hospital
      • Indianapolis, Indiana, Estados Unidos, 46312
        • Saint Catherine Hospital
      • Mooresville, Indiana, Estados Unidos, 46158
        • Franciscan Health Mooresville
      • Munster, Indiana, Estados Unidos, 46321
        • The Community Hospital
      • Munster, Indiana, Estados Unidos, 46321
        • Women's Diagnostic Center - Munster
      • Valparaiso, Indiana, Estados Unidos, 46383
        • Northwest Cancer Center - Valparaiso
    • Iowa
      • Iowa City, Iowa, Estados Unidos, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kansas
      • Fairway, Kansas, Estados Unidos, 66205
        • University of Kansas Clinical Research Center
      • Kansas City, Kansas, Estados Unidos, 66160
        • University of Kansas Cancer Center
      • Overland Park, Kansas, Estados Unidos, 66211
        • University of Kansas Hospital-Indian Creek Campus
      • Westwood, Kansas, Estados Unidos, 66205
        • University of Kansas Hospital-Westwood Cancer Center
    • Kentucky
      • Edgewood, Kentucky, Estados Unidos, 41017
        • Saint Elizabeth Healthcare Edgewood
    • Louisiana
      • Baton Rouge, Louisiana, Estados Unidos, 70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, Estados Unidos, 70808
        • Our Lady of The Lake
      • Baton Rouge, Louisiana, Estados Unidos, 70817
        • Woman's Hospital
      • Baton Rouge, Louisiana, Estados Unidos, 70817
        • Our Lady of the Lake Medical Oncology
      • Baton Rouge, Louisiana, Estados Unidos, 70808
        • Our Lady of the Lake Physician Group
      • Metairie, Louisiana, Estados Unidos, 70006
        • East Jefferson General Hospital
      • New Orleans, Louisiana, Estados Unidos, 70121
        • Ochsner Medical Center Jefferson
      • New Orleans, Louisiana, Estados Unidos, 70112
        • University Medical Center New Orleans
      • New Orleans, Louisiana, Estados Unidos, 70115
        • Ochsner Baptist Medical Center
    • Maine
      • Augusta, Maine, Estados Unidos, 04330
        • Harold Alfond Center for Cancer Care
      • Belfast, Maine, Estados Unidos, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, Estados Unidos, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brewer, Maine, Estados Unidos, 04412
        • Lafayette Family Cancer Center-EMMC
      • Rockport, Maine, Estados Unidos, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Estados Unidos, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, Estados Unidos, 04074
        • MaineHealth Maine Medical Center- Scarborough
    • Maryland
      • Annapolis, Maryland, Estados Unidos, 21401
        • Luminis Health Anne Arundel Medical Center
      • Baltimore, Maryland, Estados Unidos, 21237
        • MedStar Franklin Square Medical Center/Weinberg Cancer Institute
      • Baltimore, Maryland, Estados Unidos, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Estados Unidos, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Estados Unidos, 21204
        • Greater Baltimore Medical Center
      • Baltimore, Maryland, Estados Unidos, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Baltimore, Maryland, Estados Unidos, 21229
        • Saint Agnes Hospital
      • Bel Air, Maryland, Estados Unidos, 21014
        • UM Upper Chesapeake Medical Center
      • Bethesda, Maryland, Estados Unidos, 20889-5600
        • Walter Reed National Military Medical Center
      • Easton, Maryland, Estados Unidos, 21601
        • University of Maryland Shore Medical Center at Easton
    • Massachusetts
      • Burlington, Massachusetts, Estados Unidos, 01805
        • Lahey Clinic
      • Lowell, Massachusetts, Estados Unidos, 01854
        • Lowell General Hospital
      • Springfield, Massachusetts, Estados Unidos, 01199
        • Baystate Medical Center
      • Winchester, Massachusetts, Estados Unidos, 01890
        • Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
      • Worcester, Massachusetts, Estados Unidos, 01605
        • UMass Memorial Medical Center - Memorial Division
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48109
        • University of Michigan Rogel Cancer Center
      • Ann Arbor, Michigan, Estados Unidos, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Flint, Michigan, Estados Unidos, 48503
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Estados Unidos, 48503
        • Genesys Hurley Cancer Institute
      • Flint, Michigan, Estados Unidos, 48503
        • Cancer Hematology Centers - Flint
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Kalamazoo, Michigan, Estados Unidos, 49007
        • West Michigan Cancer Center
      • Kalamazoo, Michigan, Estados Unidos, 49007
        • Bronson Methodist Hospital
      • Lansing, Michigan, Estados Unidos, 48912
        • University of Michigan Health - Sparrow Lansing
      • Traverse City, Michigan, Estados Unidos, 49684
        • Munson Medical Center
    • Minnesota
      • Bemidji, Minnesota, Estados Unidos, 56601
        • Sanford Joe Lueken Cancer Center
      • Duluth, Minnesota, Estados Unidos, 55805
        • Essentia Health Cancer Center
      • Rochester, Minnesota, Estados Unidos, 55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson, Mississippi, Estados Unidos, 39216
        • University of Mississippi Medical Center
      • Jackson, Mississippi, Estados Unidos, 39202
        • Mississippi Baptist Medical Center
    • Missouri
      • Kansas City, Missouri, Estados Unidos, 64111
        • Saint Luke's Hospital of Kansas City
      • Springfield, Missouri, Estados Unidos, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Estados Unidos, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Estados Unidos, 63141
        • Mercy Hospital Saint Louis
    • Montana
      • Anaconda, Montana, Estados Unidos, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Estados Unidos, 59101
        • Billings Clinic Cancer Center
    • Nebraska
      • Grand Island, Nebraska, Estados Unidos, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Omaha, Nebraska, Estados Unidos, 68114
        • Nebraska Methodist Hospital
      • Omaha, Nebraska, Estados Unidos, 68198
        • University of Nebraska Medical Center
    • New Hampshire
      • Lebanon, New Hampshire, Estados Unidos, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Basking Ridge, New Jersey, Estados Unidos, 07920
        • Memorial Sloan Kettering Basking Ridge
      • Camden, New Jersey, Estados Unidos, 08103
        • Cooper Hospital University Medical Center
      • Lakewood, New Jersey, Estados Unidos, 08701
        • Monmouth Medical Center Southern Campus
      • Livingston, New Jersey, Estados Unidos, 07039
        • Cooperman Barnabas Medical Center
      • Long Branch, New Jersey, Estados Unidos, 07740
        • Monmouth Medical Center
      • Middletown, New Jersey, Estados Unidos, 07748
        • Memorial Sloan Kettering Monmouth
      • Montvale, New Jersey, Estados Unidos, 07645
        • Memorial Sloan Kettering Bergen
      • Neptune City, New Jersey, Estados Unidos, 07753
        • Jersey Shore Medical Center
      • New Brunswick, New Jersey, Estados Unidos, 08903
        • Rutgers Cancer Institute of New Jersey
      • Paramus, New Jersey, Estados Unidos, 07652
        • The Valley Hospital - Luckow Pavilion
      • Ridgewood, New Jersey, Estados Unidos, 07450
        • Neurosurgeons of New Jersey-Ridgewood
      • Ridgewood, New Jersey, Estados Unidos, 07450
        • Valley Health System Ridgewood Campus
      • Somerville, New Jersey, Estados Unidos, 08876
        • Robert Wood Johnson University Hospital Somerset
      • Toms River, New Jersey, Estados Unidos, 08755
        • Community Medical Center
      • Voorhees Township, New Jersey, Estados Unidos, 08043
        • MD Anderson Cancer Center at Cooper-Voorhees
      • Wayne, New Jersey, Estados Unidos, 07470
        • Valley Medical Group - Wayne Multispecialty Practice
      • Westwood, New Jersey, Estados Unidos, 07675
        • Valley Health System-Hematology/Oncology
    • New Mexico
      • Albuquerque, New Mexico, Estados Unidos, 87106
        • Southwest Gynecologic Oncology Associates Inc
      • Albuquerque, New Mexico, Estados Unidos, 87106
        • University of New Mexico Cancer Center
    • New York
      • Bay Shore, New York, Estados Unidos, 11706
        • Northwell Health Imbert Cancer Center
      • Brightwaters, New York, Estados Unidos, 11718
        • Island Gynecologic Oncology
      • Brooklyn, New York, Estados Unidos, 11215
        • New York-Presbyterian/Brooklyn Methodist Hospital
      • Buffalo, New York, Estados Unidos, 14263
        • Roswell Park Cancer Institute
      • Commack, New York, Estados Unidos, 11725
        • Memorial Sloan Kettering Commack
      • Flushing, New York, Estados Unidos, 11355
        • The New York Hospital Medical Center of Queens
      • Harrison, New York, Estados Unidos, 10604
        • Memorial Sloan Kettering Westchester
      • Lake Success, New York, Estados Unidos, 11042
        • Northwell Health/Center for Advanced Medicine
      • Mineola, New York, Estados Unidos, 11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park, New York, Estados Unidos, 11040
        • Long Island Jewish Medical Center
      • New York, New York, Estados Unidos, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Estados Unidos, 10029
        • Mount Sinai Hospital
      • New York, New York, Estados Unidos, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York, New York, Estados Unidos, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Estados Unidos, 10011
        • Mount Sinai Chelsea
      • New York, New York, Estados Unidos, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Estados Unidos, 14642
        • University of Rochester
      • Rochester, New York, Estados Unidos, 14620
        • Highland Hospital
      • Staten Island, New York, Estados Unidos, 10305
        • Staten Island University Hospital
      • Stony Brook, New York, Estados Unidos, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Estados Unidos, 13210
        • State University of New York Upstate Medical University
      • The Bronx, New York, Estados Unidos, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, Estados Unidos, 10467
        • Montefiore Medical Center - Moses Campus
      • Uniondale, New York, Estados Unidos, 11553
        • Memorial Sloan Kettering Nassau
      • Valhalla, New York, Estados Unidos, 10595
        • Westchester Medical Center
    • North Carolina
      • Chapel Hill, North Carolina, Estados Unidos, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Estados Unidos, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Clinton, North Carolina, Estados Unidos, 28328
        • Southeastern Medical Oncology Center-Clinton
      • Concord, North Carolina, Estados Unidos, 28025
        • Atrium Health Cabarrus/LCI-Concord
      • Goldsboro, North Carolina, Estados Unidos, 27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Hendersonville, North Carolina, Estados Unidos, 28791
        • Margaret R Pardee Memorial Hospital
      • Jacksonville, North Carolina, Estados Unidos, 28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Wilmington, North Carolina, Estados Unidos, 28401
        • Novant Health New Hanover Regional Medical Center
      • Winston-Salem, North Carolina, Estados Unidos, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Bismarck, North Dakota, Estados Unidos, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Estados Unidos, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Estados Unidos, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Estados Unidos, 44304
        • Summa Health System - Akron Campus
      • Beachwood, Ohio, Estados Unidos, 44122
        • UHHS-Chagrin Highlands Medical Center
      • Canton, Ohio, Estados Unidos, 44710
        • Aultman Health Foundation
      • Centerville, Ohio, Estados Unidos, 45459
        • Miami Valley Hospital South
      • Chardon, Ohio, Estados Unidos, 44024
        • Geauga Hospital
      • Cincinnati, Ohio, Estados Unidos, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cincinnati, Ohio, Estados Unidos, 45220
        • Good Samaritan Hospital - Cincinnati
      • Cleveland, Ohio, Estados Unidos, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Estados Unidos, 44109
        • MetroHealth Medical Center
      • Cleveland, Ohio, Estados Unidos, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Estados Unidos, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Estados Unidos, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Estados Unidos, 43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus, Ohio, Estados Unidos, 43219
        • The Mark H Zangmeister Center
      • Mayfield Heights, Ohio, Estados Unidos, 44124
        • Hillcrest Hospital Cancer Center
      • Mentor, Ohio, Estados Unidos, 44060
        • UH Seidman Cancer Center at Lake Health Mentor Campus
      • Sylvania, Ohio, Estados Unidos, 43560
        • ProMedica Flower Hospital
      • West Chester, Ohio, Estados Unidos, 45069
        • University of Cincinnati Cancer Center-West Chester
      • Westlake, Ohio, Estados Unidos, 44145
        • UH Seidman Cancer Center at Saint John Medical Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Estados Unidos, 74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
    • Oregon
      • Bend, Oregon, Estados Unidos, 97701
        • Saint Charles Health System
      • Ontario, Oregon, Estados Unidos, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Portland, Oregon, Estados Unidos, 97210
        • Legacy Good Samaritan Hospital and Medical Center
      • Portland, Oregon, Estados Unidos, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Estados Unidos, 97225
        • Providence Saint Vincent Medical Center
      • Tualatin, Oregon, Estados Unidos, 97062
        • Legacy Meridian Park Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Estados Unidos, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Estados Unidos, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Estados Unidos, 17822
        • Geisinger Medical Center
      • Ephrata, Pennsylvania, Estados Unidos, 17522
        • Ephrata Cancer Center
      • Gettysburg, Pennsylvania, Estados Unidos, 17325
        • Adams Cancer Center
      • Hanover, Pennsylvania, Estados Unidos, 17331
        • WellSpan Medical Oncology and Hematology
      • Hazleton, Pennsylvania, Estados Unidos, 18201
        • Geisinger Medical Center-Cancer Center Hazleton
      • Jefferson Hills, Pennsylvania, Estados Unidos, 15025
        • Jefferson Hospital
      • Johnstown, Pennsylvania, Estados Unidos, 15901
        • UPMC-Johnstown/John P. Murtha Regional Cancer Center
      • Lancaster, Pennsylvania, Estados Unidos, 17601
        • Lancaster General Ann B Barshinger Cancer Institute
      • Lancaster, Pennsylvania, Estados Unidos, 17602
        • Lancaster General Hospital
      • Lebanon, Pennsylvania, Estados Unidos, 17042
        • Sechler Family Cancer Center
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • Forbes Hospital
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • UPMC Hillman Cancer Center - Monroeville
      • Philadelphia, Pennsylvania, Estados Unidos, 19107
        • Thomas Jefferson University Hospital
      • Pittsburgh, Pennsylvania, Estados Unidos, 15224
        • West Penn Hospital
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • UPMC Hillman Cancer Center
      • Pittsburgh, Pennsylvania, Estados Unidos, 15213
        • UPMC-Magee Womens Hospital
      • Pottsville, Pennsylvania, Estados Unidos, 17901
        • Geisinger Cancer Services-Pottsville
      • Scranton, Pennsylvania, Estados Unidos, 18510
        • Community Medical Center
      • West Reading, Pennsylvania, Estados Unidos, 19611
        • Reading Hospital
      • Wexford, Pennsylvania, Estados Unidos, 15090
        • Wexford Health and Wellness Pavilion
      • Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
      • Willow Grove, Pennsylvania, Estados Unidos, 19090
        • Asplundh Cancer Pavilion
      • York, Pennsylvania, Estados Unidos, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, Estados Unidos, 17403
        • WellSpan Health-York Hospital
    • Rhode Island
      • Providence, Rhode Island, Estados Unidos, 02905
        • Women and Infants Hospital
    • South Carolina
      • Charleston, South Carolina, Estados Unidos, 29425
        • Medical University of South Carolina
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Estados Unidos, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Estados Unidos, 29601
        • Saint Francis Hospital
      • Seneca, South Carolina, Estados Unidos, 29672
        • Prisma Health Cancer Institute - Seneca
    • South Dakota
      • Rapid City, South Dakota, Estados Unidos, 57701
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Estados Unidos, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Estados Unidos, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Memphis, Tennessee, Estados Unidos, 38120
        • Baptist Memorial Hospital and Cancer Center-Memphis
      • Nashville, Tennessee, Estados Unidos, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Dallas, Texas, Estados Unidos, 75235
        • Parkland Memorial Hospital
      • Dallas, Texas, Estados Unidos, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Houston, Texas, Estados Unidos, 77030
        • Houston Methodist Hospital
      • Houston, Texas, Estados Unidos, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Houston, Texas, Estados Unidos, 77070
        • Methodist Willowbrook Hospital
      • Houston, Texas, Estados Unidos, 77030
        • Ben Taub General Hospital
      • Sugar Land, Texas, Estados Unidos, 77479
        • Houston Methodist Sugar Land Hospital
      • The Woodlands, Texas, Estados Unidos, 77385
        • Houston Methodist The Woodlands Hospital
    • Utah
      • Salt Lake City, Utah, Estados Unidos, 84112
        • Huntsman Cancer Institute/University of Utah
      • Salt Lake City, Utah, Estados Unidos, 84106
        • University of Utah Sugarhouse Health Center
    • Vermont
      • Burlington, Vermont, Estados Unidos, 05401
        • University of Vermont Medical Center
    • Virginia
      • Charlottesville, Virginia, Estados Unidos, 22908
        • University of Virginia Cancer Center
      • Richmond, Virginia, Estados Unidos, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Gig Harbor, Washington, Estados Unidos, 98335
        • MultiCare Gig Harbor Medical Park
      • Kennewick, Washington, Estados Unidos, 99336
        • Kadlec Clinic Hematology and Oncology
      • Puyallup, Washington, Estados Unidos, 98372
        • MultiCare Good Samaritan Hospital
      • Renton, Washington, Estados Unidos, 98055
        • Valley Medical Center
      • Seattle, Washington, Estados Unidos, 98122
        • Swedish Medical Center-First Hill
      • Tacoma, Washington, Estados Unidos, 98405
        • MultiCare Tacoma General Hospital
      • Vancouver, Washington, Estados Unidos, 98686
        • Legacy Salmon Creek Hospital
    • West Virginia
      • Charleston, West Virginia, Estados Unidos, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Estados Unidos, 26506
        • West Virginia University Healthcare
      • Morgantown, West Virginia, Estados Unidos, 26505
        • Monongalia Hospital
    • Wisconsin
      • Burlington, Wisconsin, Estados Unidos, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Eau Claire, Wisconsin, Estados Unidos, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Germantown, Wisconsin, Estados Unidos, 53022
        • Aurora Health Care Germantown Health Center
      • Grafton, Wisconsin, Estados Unidos, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, Estados Unidos, 54311
        • Aurora BayCare Medical Center
      • Kenosha, Wisconsin, Estados Unidos, 53142
        • Aurora Cancer Care-Kenosha South
      • Madison, Wisconsin, Estados Unidos, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marinette, Wisconsin, Estados Unidos, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marshfield, Wisconsin, Estados Unidos, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Estados Unidos, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, Estados Unidos, 53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee, Wisconsin, Estados Unidos, 53233
        • Aurora Sinai Medical Center
      • Minocqua, Wisconsin, Estados Unidos, 54548
        • Marshfield Medical Center - Minocqua
      • Oconomowoc, Wisconsin, Estados Unidos, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, Estados Unidos, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Racine, Wisconsin, Estados Unidos, 53406
        • Aurora Cancer Care-Racine
      • Rice Lake, Wisconsin, Estados Unidos, 54868
        • Marshfield Medical Center-Rice Lake
      • Sheboygan, Wisconsin, Estados Unidos, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Stevens Point, Wisconsin, Estados Unidos, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Summit, Wisconsin, Estados Unidos, 53066
        • Aurora Medical Center in Summit
      • Two Rivers, Wisconsin, Estados Unidos, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Waukesha, Wisconsin, Estados Unidos, 53188
        • UW Cancer Center at ProHealth Care
      • Wauwatosa, Wisconsin, Estados Unidos, 53226
        • Aurora Cancer Care-Milwaukee West
      • West Allis, Wisconsin, Estados Unidos, 53227
        • Aurora West Allis Medical Center
      • Weston, Wisconsin, Estados Unidos, 54476
        • Marshfield Medical Center - Weston
      • Saitama, Japão, 350-1298
        • Saitama Medical University International Medical Center
    • Ehime
      • Tōon, Ehime, Japão, 791-0295
        • Ehime University Hospital
    • Hiroshima
      • Kure, Hiroshima, Japão, 737
        • Kure Medical Center and Chugoku Cancer Center
    • Niigata
      • Niigata, Niigata, Japão, 951-8520
        • Niigata University Medical and Dental Hospital
      • San Juan, Porto Rico, 00927
        • Centro Comprensivo de Cancer de UPR

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  • Measurable stage III, measurable stage IVA, stage IVB (with or without measurable disease) or recurrent (with or without measurable disease) endometrial cancer.

  • Pathology report showing results of institutional MMR IHC testing.

  • Histologic confirmation of the original primary tumor is required (submission of pathology report(s) is required). Patients with the following histologic types are eligible: Endometrioid adenocarcinoma, serous adenocarcinoma, dedifferentiated/undifferentiated carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, adenocarcinoma not otherwise specified (N.O.S.).

  • Submission of tumor specimens for centralized MMR IHC testing is required after Step 1 and before Step 2 registration.

  • In patients with measurable disease, lesions will be defined and monitored by RECIST version (v) 1.1. Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be >= 10 mm when measured by CT or magnetic resonance imaging (MRI). Lymph nodes must be >= 15 mm in short axis when measured by CT or MRI.

  • Patients may have received

    • NO prior chemotherapy for treatment of endometrial cancer OR
    • Prior adjuvant chemotherapy (e.g., paclitaxel/carboplatin alone or as a component of concurrent chemotherapy and radiation therapy [with or without cisplatin]) provided adjuvant chemotherapy was completed >= 12 months prior to STEP 2 registration.
  • Patients may have received prior radiation therapy for treatment of endometrial cancer. Prior radiation therapy may have included pelvic radiation therapy, extended field pelvic/para aortic radiation therapy, intravaginal brachytherapy, and/or palliative radiation therapy. All radiation therapy must be completed at least 4 weeks prior to STEP 2 registration.

  • Patients may have received prior hormonal therapy for treatment of endometrial cancer. All hormonal therapy must be discontinued at least three weeks prior to STEP 2 registration.

  • Interval or cytoreductive surgery, after start of treatment on this trial, and prior to documentation of disease progression, is NOT permitted.

  • Age >= 18.

  • Performance status of 0, 1 or 2.

  • Platelets >= 100,000/mcl.

  • Absolute neutrophil count (ANC) >= 1,500/mcl.

  • Creatinine =< 1.5 x institutional/laboratory upper limit of normal (ULN).

  • Total serum bilirubin level =< 1.5 x ULN (patients with known Gilbert's disease who have bilirubin level =< 3 x ULN may be enrolled).

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN.

  • Thyroid stimulating hormone (TSH) within normal limits. If TSH is not within normal range despite no symptoms of thyroid dysfunction, normal Free T4 level is required.

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of Step 2 registration are eligible for this trial.

  • For patients of child bearing potential: negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test is required.

  • Administration of study drugs (pembrolizumab [MK-3475], paclitaxel, carboplatin) may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality. Women of childbearing potential (WOCBP) must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) from at least 14 days prior to Step 2 registration (for oral contraceptives), during treatment, and for 120 days after the last dose of study medication. Should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform her treating physician immediately. Patients will be considered of nonreproductive potential if they are either:

    • Postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age, a high follicle stimulating hormone (FSH) level in the postmenopausal range may be used to confirm a postmenopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient); OR
    • Have a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion, at least 6 weeks prior to Step 2 registration; OR
    • Have a congenital or acquired condition that prevents childbearing.
  • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.

  • The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information.

Exclusion Criteria:

  • Patients with prior treatment with anti-PD-1, anti-PD-L1 or anti-CTLA-4 therapeutic antibody or other similar agents.

  • Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) and/or its excipients; and/or a severe hypersensitivity reaction to paclitaxel and/or carboplatin.

  • Patients who are currently participating and receiving cancer-directed study therapy or have participated in a study of an investigational agent and received cancer-directed study therapy within 4 weeks prior to Step 2 registration.

  • Patients who have a diagnosis of immunodeficiency or are receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to Step 2 registration.

    • Patients who have received steroids as CT scan contrast premedication may be enrolled.
    • The use of inhaled or topical corticosteroids is allowed.
    • The use of mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed.
    • The use of physiologic doses of corticosteroids may be approved after consultation with the study chair.
  • Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression, and they have been off steroids for at least 4 weeks prior to Step 2 registration and remain clinically stable.

  • Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease.

  • Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.

  • Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible.

  • Patients who have a history of (non-infectious) pneumonitis that required steroids, or current pneumonitis.

  • Uncontrolled intercurrent illness including, but not limited to: ongoing or active infection (except for uncomplicated urinary tract infection), interstitial lung disease or active, non-infectious pneumonitis, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.

  • Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; and cirrhosis.

    • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
    • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.
  • Pregnant or lactating patients.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Quadruplicar

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Arm I (placebo, paclitaxel, carboplatin)

COMBINATION PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive placebo IV over 30 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo CT scan throughout the study.

On February 6, 2023, all patient treatment assignments were unblinded. Patients randomized to Arm 1 will not receive additional placebo infusions.

Given IV

Outros nomes:
  • Blastocarbe
  • Carboplat
  • Carboplatina Hexal
  • Carboplatina
  • Carbosina
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatina
  • Paraplatina
  • Paraplatina AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Outros nomes:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Ancillary studies

Outros nomes:
  • Avaliação da Qualidade de Vida

Given IV

Ancillary studies

Undergo CT scan

Outros nomes:
  • TC
  • GATO
  • Tomografia
  • Tomografia Axial Computadorizada
  • Tomografia computadorizada
  • tomografia
  • Tomografia axial computadorizada (procedimento)
  • Tomografia computadorizada (TC)
  • Diagnóstico Cat Scan
  • Tipo de serviço de varredura de gato diagnóstico
Experimental: Arm II (pembrolizumab, paclitaxel, carboplatin)

COMBINATION PHASE: Patients receive pembrolizumab IV over 30 minutes on day 1 of each cycle, paclitaxel IV over 3 hours on day 1 of each cycle, and carboplatin IV over 30 minutes on day 1 of each cycle. Treatment repeats every 3 weeks for 6 cycles in the absence of disease progression or unacceptable toxicity. Patients with SD or PR who still have measurable disease may continue treatment for up to a total of 10 cycles (if deemed necessary by the treating physician) in the absence of disease progression or unacceptable toxicity.

MAINTENANCE PHASE: Patients receive pembrolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 6 weeks for up to 14 cycles in the absence of disease progression or unacceptable toxicity.

Patients undergo CT scan throughout the study.

Given IV

Outros nomes:
  • Blastocarbe
  • Carboplat
  • Carboplatina Hexal
  • Carboplatina
  • Carbosina
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatina
  • Paraplatina
  • Paraplatina AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Outros nomes:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Ancillary studies

Outros nomes:
  • Avaliação da Qualidade de Vida

Ancillary studies

Given IV

Outros nomes:
  • Keytruda
  • MK-3475
  • Lambrolizumabe
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumabe Biossimilar BCD-201
  • Pembrolizumabe Biossimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumabe Biossimilar GME751
  • SCH900475
  • Pembrolizumabe Biossimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab biossimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo CT scan

Outros nomes:
  • TC
  • GATO
  • Tomografia
  • Tomografia Axial Computadorizada
  • Tomografia computadorizada
  • tomografia
  • Tomografia axial computadorizada (procedimento)
  • Tomografia computadorizada (TC)
  • Diagnóstico Cat Scan
  • Tipo de serviço de varredura de gato diagnóstico

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Progression-free Survival (PFS)
Prazo: Duration of time from study entry to time of progression per RECIST criteria or death due to any cause, whichever occurs first. The interquartile range for follow-up was (6.37 months, 30.62 months). The maximum for follow-up was 37.85 months.

Progression free survival (PFS) Note: For arm 2 (dMMR Cohort), the point estimate and the upper limit of the confidence interval are not able to be estimated due to insufficient events.

Duration of time from study entry to time of progression per RECIST criteria or death due to any cause, whichever occurs first. The interquartile range for follow-up was (6.37 months, 30.62 months). The maximum for follow-up was 37.85 months.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Adverse Events With Grade 3 (or Higher)
Prazo: For the adverse event time frame, the interquartile range was (0.79 months, 3.42 months); the maximum was 28.39 months.

Assessed by Common Terminology Criteria for Adverse Events (CTCAE V5.0). The endpoint is the count of participants with an adverse event of grade 3 (or higher) by treatment group.

For the adverse event time frame, the interquartile range was (0.79 months, 3.42 months); the maximum was 28.39 months.
Objective Tumor Response
Prazo: For the time frame for tumor response, the interquartile range was (2.27 months, 8.66 months) and the maximum was 36.37 months.

Assessed by Response Evaluation Criteria for Solid Tumors (RECIST) 1.1.

For the time frame for tumor response, the interquartile range was (2.27 months, 8.66 months) and the maximum was 36.37 months.
Duration of Objective Response
Prazo: For the duration of objective response, the interquartile range is (4.24 months, 7.92 months); the maximum is 28.68 months.

The time difference between the dates of first response and first progression; patients who do not progress are considered censored. Note: for Arm 2 (dMMR Cohort), the upper limit of the confidence interval is not able to be estimated due to an insufficient number of events.

For the duration of objective response, the interquartile range is (4.24 months, 7.92 months); the maximum is 28.68 months.
Overall Survival (OS)
Prazo: Time from study entry to time of death or the date of last contact, assessed up to 5 years

Overall Survival (OS). This endpoint will be assessed by Kaplan-Meier.

Time from study entry to time of death or the date of last contact, assessed up to 5 years
Quality of Life (QoL) in pMMR Patients Only
Prazo: 0-54 weeks from start of treatment

QoL are collected in pMMR patients only and measured with the Function Assessment of Cancer Therapy -Endometrial Trial Outcome Index (FACT En-TOI). The FACT-En TOI scores range 0 - 120 with a larger score suggesting better or favorable state of QOL.

0-54 weeks from start of treatment
Concordance Between Institutional Mismatch Repair (MMR) Immunohistochemistry (IHC) Testing and Centralized MMR IHC
Prazo: IHC testing values (for both central and institutional) were collected at baseline.

Concordance between institutional MMR IHC testing and centralized MMR IHC. The concordance of institutional MMR IHC testing and centralized MMR IHC will be characterized by agreement statistics including the kappa statistic (e.g. Cohen's kappa coefficient).

IHC testing values (for both central and institutional) were collected at baseline.

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Incidence of Pembrolizumab Treatment and Self-reported Neurotoxicity
Prazo: 0-54 weeks from start of treatment

Patient-reported neurotoxicity will be measured with FACT/GOG-Ntx subscale (short form).

0-54 weeks from start of treatment
Effect of Pembrolizumab on PFS and OS by Program Death Ligand 1 (PD-L1) IHC
Prazo: 5 years

Will assess the effect of pembrolizumab on PFS and OS by PD-L1 (combined positive score [CPS]) within proficient MMR (pMMR) and deficient MMR (dMMR) populations. The effectiveness of pembrolizumab will be compared by PD-L1 status (CPS). A formal test will be conducted by examining the interaction term between pembrolizumab treatment (yes or no) with PD-L1 status. The association between PD-L1 CPS status and MMR IHC status will be assessed with odds ratios. A test may be conducted with a Fisher's Exact Test, and confidence intervals will be provided.

5 years
Association Between PD-L1 IHC and MMR Status
Prazo: 5 years

Measures of association between PD-L1 IHC (CPS) and MMR IHC status. The concordance of institutional MMR IHC testing and centralized MMR IHC will be characterized by agreement statistics such as kappa statistics (e.g. Cohen's kappa coefficient).

5 years

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Ramez N Eskander, NRG Oncology

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

22 de agosto de 2019

Conclusão Primária (Real)

16 de dezembro de 2022

Conclusão do estudo (Estimado)

26 de setembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

12 de abril de 2019

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de abril de 2019

Primeira postagem (Real)

16 de abril de 2019

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Sim

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever